Buying a Specialty Chemicals Business as a Second Career
Thousands of small chemical and ingredient companies need a successor. Why industry veterans make good buyers, how an individual finances the deal, and how to keep the key accounts in year one.
Key takeaways
- Succession is a real gap: about 186,000 handovers are expected in Germany between 2026 and 2030, and around 370,000 French companies could be for sale within five years, against roughly 26,000 that actually changed hands in 2024.
- Experienced industry people make strong buyers of small specialty chemicals and ingredients businesses, because they can judge customers, regulatory files and supply risk that a financial buyer reads only on paper.
- In both countries an individual can finance a buyout with personal equity, bank debt and public support: in France a seller loan, an honour loan and a Bpifrance guarantee; in Germany the KfW ERP loan for succession.
- Check four things before you sign: how concentrated the customers are, which accounts depend on the founder, who holds the regulatory dossiers, and which raw materials have a single source.
- In the first year, protect the key accounts. Visit them with the founder, keep prices stable and change the commercial setup slowly.
Thousands of small chemical and ingredient companies in France and Germany will need a new owner in the next few years. Many of the best possible buyers are sitting in the industry right now, in senior jobs at large groups, wondering what the next ten years should look like. I think buying one of those companies is one of the smartest second careers in our industry.
The succession gap reaches our industry too
In Germany, IfM Bonn expects about 186,000 company handovers between 2026 and 2030, and KfW counts around 109,000 planned successions a year until 2029. In France, a 2025 Bpifrance study of 5,000 business owners puts the number of companies that could be sold within five years at about 370,000. In 2024, about 26,000 actually changed hands. The same study found that 43 % of owners are over 60.
Only a small share of these are chemical companies, but our industry has plenty of the profiles that show up in these figures: a formulator with 25 people and a loyal customer base, a niche distributor covering one country and three markets, a toll manufacturer whose founder still answers the hardest technical questions. Many were built by one person in the 1990s. The children often have other plans.
When nobody takes over, one of two things happens. The company closes, or it gets sold to a larger player and folded in.
Why I prefer an ambitious owner to a big group
I spent 15 years inside large groups and I respect what they do well: scale, process, reach. Some acquisitions by big distributors and producers work very well for everyone.
Still, I think a small company is usually better off when it is taken over by ambitious, enthusiastic people than when it is absorbed into a big organisation. In a 30-person company, everybody's contribution is visible. The application chemist who solved the customer's stability problem, the planner who knows which reactor to free up on a Friday, the sales manager who has visited the same buyers for 15 years. In a large group those people become a line in an integration plan, and their work is rarely valued in the same way. Some of them leave.
Customers notice. The contact person changes, the decision that took one phone call now takes three approvals, and the flexibility that made them buy from a small supplier disappears. It would be a pity to lose good teams that way when someone with industry experience could have kept them together and grown the business.
Why experienced industry people make good buyers
A senior commercial or technical person from our industry starts with advantages a financial buyer has to pay advisers for.
You can read a customer list and know which names are solid and which buy on price only. You know what a REACH registration or a food or cosmetic regulatory file is worth, and what it costs to rebuild. You know which raw materials are tight and which suppliers behave well in a shortage. You can sit across from the founder and talk about the business in their language, which matters more than most buyers think. Founders want to sell to someone who will look after what they built.
What you usually lack is experience as an owner: cash management, banks, payroll, and being the last person who decides. That can be learned, and a good seller handover and a trusted accountant cover much of it in year one.
How the financing works for an individual buyer
The usual structure is a leveraged buyout. You set up a holding company, put in your own equity, and the holding borrows the rest from a bank. The target company's profits pay back the debt over the following years. This is general information, not financing advice. Your bank and your adviser will set the real terms.
In France
French banks typically expect equity of around 30 % of the price and lend the rest over about seven years, with repayments the company's cash flow can carry. Several tools help close the gap:
- Crédit vendeur: the seller agrees to be paid part of the price later, usually over one to three years. Banks like it because it shows the seller believes in the business.
- Prêt d'honneur: a personal, interest-free loan from Initiative France or Réseau Entreprendre that strengthens your equity. Bpifrance's Prêt d'honneur Création-Reprise adds between 1,000 and 80,000 euros for people those networks back.
- Bpifrance guarantee: the Garantie Transmission covers 50 % of the bank loan, up to 70 % when the region joins in. It protects the bank, not you, and the company pays a fee for it.
In Germany
The KfW ERP-Förderkredit Gründung und Nachfolge has been available since November 2024. It lends up to 500,000 euros and can cover up to 35 % of eligible costs, including the purchase price. The house bank carries no default risk on it, because a Bürgschaftsbank guarantees it with a federal counter-guarantee. You apply through your own bank.
Earn-out and the seller's time
Part of the price is often tied to results in the years after the deal. Agree how long the seller stays in the business and in what role. In a company where key customers know only the founder, a short handover is the most expensive thing you can negotiate.
What to check before you sign
A standard due diligence covers the accounts and the contracts. In specialty chemicals and ingredients I would add five questions.
- How concentrated are the customers? If three accounts make half the sales, find out why they buy and how long their contracts run.
- Which accounts depend on the founder? Ask who the buyer calls when something goes wrong. If the answer is always the founder, the handover plan matters more than the price.
- Who holds the regulatory dossiers? Check REACH registrations, food and cosmetic files and certifications. Are they in the company's name, up to date, and is someone besides the founder able to maintain them?
- Which raw materials have a single source? One supplier for a key intermediate is a risk you buy along with the company.
- How old is the equipment? Reactors, filling lines and the lab all need investment eventually. Put a number on it before the bank does.
Integration is the hard part, for big groups and new owners
Integrations are a tough game, and large groups know it as well as anyone. Systems, pricing policies, product ranges and people have to fit together, and every change reaches customers. Even well-run integrations lose some accounts on the way.
A new individual owner avoids most of that, because the company stays whole. The risk moves to the first year after the deal, and most of it sits with the key accounts.
Key accounts should hear about the change from the founder and from you, together, before the market tells them. Plan joint visits to the top accounts in the first months, so the relationship moves from the founder to the new owner in front of the customer.
Keep prices and terms stable. A price change in year one tells every buyer to test a competitor.
Projects where a customer is testing or approving a product take months, and they are easy to lose in a handover. Give each one a named owner on your side.
This is the kind of work where an experienced commercial lead can help for a year or two, on a fractional basis, until the team runs the accounts on its own.
Where AI helps in a handover
In many small companies the most valuable knowledge sits in the founder's head: why a customer gets a certain price, which product works in which formulation, which supplier to call first. Writing that down before the handover protects the value you are buying. On opencream.ai I wrote about how AI helps capture that knowledge before a sale: Business Succession: The Know-How in the Owner's Head.
A good second chapter
Our industry is full of people with deep market knowledge who are asking what comes after the corporate career. Many small chemical and ingredient companies are asking who comes after the founder. When those two meet, the team stays together, customers keep dealing with people who know them, and someone with 20 years in the industry gets a business of their own to grow.
Frequently asked questions
How much equity do I need to buy a small company in France?
Is there public financing for business succession in Germany?
Why would a founder sell to an individual instead of a large group?
What is the biggest risk in buying a small specialty chemicals company?
How long should the seller stay after the deal?
Launching an ingredient or opening a new market?
Book a 15-minute call and we'll see where I can help.
Book a Call